By pushing a 75 percent wholesale tax on nicotine pouches, New York State Budget Director Blake Washington says, Gov. Kathy Hochul is trying to address “a public health concern.” That rationale is absurd on its face, since this tax would sharply raise the cost of a nicotine product that is far less hazardous than cigarettes, perversely discouraging smokers from making a switch that could save their lives.
Hochul, who seems determined to portray a money grab as a benevolent intervention, is either oblivious or indifferent to the health consequences of taxing nicotine patches at the same rate as cigarettes. “We see it as a distinction without a difference,” Washington told reporters in January.
That position ignores the huge difference between inhaling tobacco smoke, which contains myriad toxins and carcinogens, and orally absorbing nicotine from a pouch placed between the lip and gums. Hochul’s framing also contradicts what the Food and Drug Administration (FDA) said four days before the end of the Biden administration, when it authorized the marketing of Zyn nicotine pouches in two doses and 10 flavors.
That decision was based on the FDA’s determination that “the new products offer greater benefits to population health than risks.” The data, said Matthew Farrelly, director of the Office of Science at the FDA’s Center for Tobacco Products, “show that these nicotine pouch products meet that bar by benefiting adults who use cigarettes and/or smokeless tobacco products and completely switch to these products.”
Nicotine pouches contain “substantially lower amounts of harmful constituents than cigarettes,” the FDA noted. They therefore offer “a lower-risk alternative for adults who smoke cigarettes.”
How much lower? To give you a sense of the difference, the Royal College of Physicians estimates that “the hazard to health” from e-cigarettes, which likewise do not contain tobacco or burn anything but do require inhalation, “is unlikely to exceed 5% of the harm from smoking tobacco.”
Nicotine pouches “contain far, far fewer harmful constituents compared to traditional tobacco products,” notes Mary Hrywna, a tobacco control specialist at the Rutgers School of Public Health. The FDA’s Zyn decision implicitly acknowledged that nicotine pouches are “much safer than cigarettes,” says Ray Niaura, a professor at New York University’s School of Global Public Health.